Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact onin vitroinflammatory responses

Disruption of the SapM locus inMycobacterium bovisBCG improves its protective efficacy as a vaccine againstM. tuberculosis

(2011) Nele Festjens et al.   EMBO Molecular Medicine

Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models

(2011) S.O. Clark et al.   JOURNAL OF APPLIED MICROBIOLOGY

Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages

(2010) M. G. BRADBURY et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Role of Phosphatidylinositol Mannosides in the Interaction between Mycobacteria and DC-SIGN

(2009) N. N. Driessen et al.   INFECTION AND IMMUNITY

Identification of Mycobacterial  -Glucan As a Novel Ligand for DC-SIGN: Involvement of Mycobacterial Capsular Polysaccharides in Host Immune Modulation

(2009) J. Geurtsen et al.   JOURNAL OF IMMUNOLOGY

The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium–host interaction

(2008) B. J. Appelmelk et al.   CELLULAR MICROBIOLOGY

MyDths and un-TOLLed truths: Sensor, instructive and effector immunity to tuberculosis

(2008) Norbert Reiling et al.   IMMUNOLOGY LETTERS

Incorporation of Mycobacterium tuberculosis Lipoarabinomannan into Macrophage Membrane Rafts Is a Prerequisite for the Phagosomal Maturation Block

(2008) A. Welin et al.   INFECTION AND IMMUNITY